Browse through 2,852 product recalls and safety alerts. Filter by hazard level, status, or search for specific products.
CheerKid recalled baby bath seats on February 12, 2026, due to drowning risks. The seats can tip over, violating safety standards. Parents should stop using them immediately and seek a refund.
Surveying Accessories Cheaper recalled Colombia-themed magnetic board games on February 12, 2026. The games pose a high risk of serious injury or death from magnet ingestion. Consumers should stop using the games immediately and seek a refund.
LShome recalled 3-Pack Smoke Detector Fire Alarms on February 12, 2026, due to a failure to warn during a fire. The defect poses a serious risk of injury or death. Consumers should stop using these alarms immediately and contact the manufacturer for a refund.
Oregon Potato Company recalled 55,689 pounds of IQF Blueberries on February 12, 2026, due to potential contamination with Listeria monocytogenes. The affected products include 30-pound cases and 1,400-pound totes distributed in Michigan, Oregon, Washington, Wisconsin, and Canada.
Slate Run Pharmaceuticals recalled Eptifibatide Injection on February 12, 2026. The recall affects all lots of the 75 mg/100 mL vial due to incorrect dosing information. Healthcare providers and consumers must stop using the product immediately.
Burlington Medical recalled 15,216 Kilt devices distributed worldwide. The recall follows a potential degradation in attenuation over time that could shorten the device lifespan. Stop using the device immediately and follow the manufacturer’s recall instructions, per the company and FDA notice dated 2026-02-11.
CareFusion 303 recalled 1,025,567 units of the BD Alaris System with Guardrails Suite MX with Point of Care Unit worldwide. The recall concerns labeling that fails to indicate which TLS version must be enabled for secure hospital Wi-Fi communication. Hospitals and clinicians should stop using the device immediately and follow manufacturer instructions. The recall was issued by the FDA and is being
Burlington Medical recalled 51 Blocker devices sold worldwide after a recall notice. The devices may degrade attenuation over time, shortening their lifespan. Stop using the devices immediately and follow the manufacturer’s recall instructions. Contact Burlington Medical, LLC or your healthcare provider for guidance. Distribution is worldwide.
Burlington Medical recalled 14,323 Frontal Aprons sold worldwide after regulators flagged attenuation degradation over time. The aprons use Xenolite 800 shielding material. Healthcare providers should stop using the devices immediately and await instructions from Burlington Medical.
Burlington Medical recalled 1,129 protective sleeves worldwide after determining attenuation degradation over time. The sleeves were manufactured with Xenolite 800 attenuation material between 2025-01-16 and 2026-01-21. The recall affects products distributed in the United States and internationally. Providers and patients should stop using the sleeve and follow recall instructions from the maker.
Burlington Medical recalled 402 Half Aprons sold worldwide after potential attenuation degradation. Attenuation material Xenolite 800 may degrade over time, reducing shielding lifespan. Patients and healthcare providers should stop using the aprons immediately and contact Burlington Medical for recall instructions.
Burlington Medical recalled 15,438 attenuation vests distributed worldwide after potential attenuation degradation over time. The vests use Xenolite 800 attenuation material and were produced between January 16, 2025 and January 21, 2026. Healthcare providers and patients should stop using the vest immediately and follow recall instructions.
Burlington Medical recalled 94 Kilt Blockers sold worldwide through distributors and healthcare providers. The devices may attenuate over time, shortening their lifespan. Stop using immediately and contact Burlington Medical or your healthcare provider for instructions.
Waldemar Link GmbH & Co. KG recalls 74 Embrace Drill Tower devices distributed in 15 U.S. states. The recall notes mixed-up article numbers in the overview of the instruments. The surgical steps are correct. Stop using the device immediately and follow manufacturer instructions.
Waldemar Link GmbH & Co. KG recalled 75 Embrace Shoulder Drill Tower devices distributed to U.S. hospitals after discovering mixed-up article numbers in the device overview. The surgical steps are correct, but the overview labeling is inaccurate. Healthcare providers should stop using the device immediately and follow manufacturer recall instructions sent by email.
Burlington Medical recalled 1,489 BAT Coverage units worldwide on 2026-02-11 after a design-related issue was identified. The recall targets attenuation material used in the device. The defect could affect the lifespan of the shielding. Healthcare providers and patients should stop using the device and follow manufacturer instructions. The recall is active as of 2026-04-08.
Burlington Medical, LLC recalled 103 leg wrap devices distributed worldwide through multiple retailers. The recall cites attenuation degradation over time that could shorten the devices' lifespan. Healthcare providers and patients should stop using them immediately and follow the manufacturer's recall instructions.
Burlington Medical recalled 5,198 wrap aprons worldwide after attenuation degradation was identified in Xenolite 800 material. The recall covers units manufactured between 01/16/2025 and 01/21/2026. Stop using the aprons immediately and follow the manufacturer’s recall instructions.
Burlington Medical recalled 29 Demi Half Aprons distributed worldwide after finding attenuation material may degrade over time. The degradation shortens the protective lifespan. Healthcare facilities should stop using the aprons immediately and follow the manufacturer’s recall instructions.
Burlington Medical recalled 961 caps used in medical devices sold to healthcare providers worldwide. The caps may experience attenuation degradation over time, shortening device lifespan. Healthcare providers and patients should stop using the affected caps and follow recall instructions.